Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
cOR | 95% CI | p-value | aOR | 95% CI | p-value | |
Total simplified Mastora score | 1.06 | 1.02–1.10 | 0.003 | 1.06 | 1.02–1.11 | 0.008 |
Male gender | 1.12 | 0.35–3.61 | 0.85 | 2.04 | 0.42–10.00 | 0.38 |
Age (years) | 1.02 | 0.98–1.05 | 0.31 | 1.02 | 0.97–1.06 | 0.51 |
Presence of comorbidity | 2.36 | 0.61–9.05 | 0.21 | 3.91 | 0.65–23.26 | 0.14 |
Patients with DVT | 2.44 | 0.76–7.86 | 0.13 | 2.36 | 0.55–10.25 | 0.25 |
Diagnosed with SARS-CoV-2 PCR | 0.39 | 0.13–1.19 | 0.098 | 0.93 | 0.23–3.83 | 0.92 |
Favipiravir treatment | 0.18 | 0.05–0.65 | 0.009 | 0.13 | 0.02–0.93 | 0.041 |
HCQ treatment | 2.47 | 0.80–7.63 | 0.12 | 0.87 | 0.16–4.62 | 0.87 |